Cannell & Co’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

Cannell & Co’s Portfolio CELGZ Stock Details CELGZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-100,000	Closed	-$62K	–	255
2019 Q2	$62K	Sell	100,000 -56,718	-36%	-$40.7K	﹤0.01%	232
2019 Q1	$174K	Sell	156,718 -31,465	-17%	-$30.8K	0.01%	238
2018 Q4	$85K	Sell	188,183 -31,100	-14%	-$28.4K	﹤0.01%	240
2018 Q3	$351K	Sell	219,283 -114,582	-34%	-$152K	0.01%	219
2018 Q2	$135K	Hold	333,865	–	–	0.01%	248
2018 Q1	$97K	Hold	333,865	–	–	﹤0.01%	240
2017 Q4	$324K	Hold	333,865	–	–	0.01%	223
2017 Q3	$506K	Hold	333,865	–	–	0.02%	195
2017 Q2	$414K	Hold	333,865	–	–	0.01%	205
2017 Q1	$361K	Hold	333,865	–	–	0.01%	217
2016 Q4	$344K	Hold	333,865	–	–	0.01%	216
2016 Q3	$347K	Hold	333,865	–	–	0.01%	221
2016 Q2	$487K	Hold	333,865	–	–	0.02%	206
2016 Q1	$437K	Hold	333,865	–	–	0.02%	210
2015 Q4	$401K	Hold	333,865	–	–	0.01%	220
2015 Q3	$538K	Hold	333,865	–	–	0.02%	201
2015 Q2	$694K	Buy	+333,865	New	+$854K	0.02%	190
2014 Q4	–	Sell	-25,000	Closed	-$85K	–	291
2014 Q3	$85K	Buy	+25,000	New	+$72.8K	﹤0.01%	266

Other funds holding CELGZ

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

Beaumont Financial Advisors Needham, Massachusetts $1.46B AUM 21.07% 1-Year Est. Return

TPA

Trivium Point Advisory Westport, Connecticut $553M AUM 26.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cannell & Co's CELGZ Position: Q3 2019 in Review

Cannell & Co sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q3 2019, closing a stake of 100,000 shares — an estimated $62K sold.

Cannell & Co first reported a position in CELGZ in Q3 2014 and held it in 18 quarters. The position peaked at $694K in Q2 2015. 24 funds tracked by Wall St. Rank hold CELGZ as of Q3 2019.

Cannell & Co reported no remaining Celgene Corporation Contingent Value Rights position as of Q3 2019 after selling out during the quarter.
Cannell & Co sold 100,000 Celgene Corporation Contingent Value Rights shares in Q3 2019, an estimated $62K.
Cannell & Co first reported a position in Celgene Corporation Contingent Value Rights in Q3 2014 and held it in 18 quarters.
Cannell & Co's Celgene Corporation Contingent Value Rights position peaked at $694K in Q2 2015.
24 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q3 2019.

Based on Cannell & Co's 13F filing for Q3 2019, filed 12 Nov 2019.